Sub-section: Thyroid Section: Endocrine

Incidence

  • Approximately 1% of all thyroid malignancies
  • Most aggressive form of Thyroid Ca
  • Disease-specific mortality ~ 100%

Clinical

  • Typically an older patient with dysphagia, cervical tenderness, and a painful, rapidly enlarging neck mass
  • Often have a history of prior or coexistent Differentiated thyroid cancer
  • Up to 50% have history of goitre
  • Clinical findings may also include SVC syndrome
  • Clinical situation deteriorates rapidly into tracheal obstruction and rapid local invasion of surrounding structures

Pathology

  • Macroscopic
    • Locally invasive, with a firm, whitish appearance
  • Microscopic
    • Giant cells with intranuclear cytoplasmic invaginations
    • Cell types range from moderately differentiated to extremely poorly differentiated cells.
    • Three types of cell populations have been classified:
      • Small spindle cell
      • Giant cell
      • Squamous
      • All have a poor prognosis
    • p53 mutations are found in 15% of tumours, a much higher rate than DTCs
    • Occasionally, squamous cell elements or islands of more recognizable DTC, such as PTC, can be identified within the locus of the tumour
    • Finding led to speculation that ATC might arise from more differentiated carcinoma – No solid proof of this theory

Management

  • Overview

    • Results of any surgical treatment tempered by its rapidly progressive clinical course
    • Distant spread is present in 90% of patients at the time of diagnosis
      • Most commonly to the lungs
    • Most reports of resection are not optimistic
      • FNA is accurate in 90% of cases, making open biopsy an uncommon surgical indication
      • Small improvement in survival may be seen after resection (if appropriate)
  • Because the prognosis is so grim, end-of-life planning and consideration of palliation must be part of early management and counselling

  • By stage

    • Small incidental finding
      • Total thyroidectomy and adjuvant chemotherapy or radiotherapy should be considered
    • Resectable locoregional disease
      • Total thyroidectomy + lymphadenectomy + adjuvant chemotherapy and radiotherapy.
      • Post-op external-beam irradiation or adjunctive chemotherapy adds little to the overall prognosis (but should be considered)
    • Unresectable disease
      • Radiotherapy and chemotherapy can be considered.
      • Should consider an isthmus division.